1st Quarter - Report

KNIGHT CAPITOL CONSULTANTS for GENZYME CORPORATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Preserve Access to Affordable Generics Act (S. 369)

LobbyistCovered position, as disclosed
PATRICIA KNIGHT previously listed

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 369 (111th)

Health Issues HCR

Health care reform legislation and particularly issues of interest to the biotechnology industry, including follow-on biologics, comparative effectiveness, orphan drugs, drugs provided at clinics under 340B of the Public Health Service Act, and import safety- H.R. 3590, the Patient Protection and Affordable Care Act, and H.R. 4872, the Hedalth care and Education Reconciliation Act of 2010.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Prof Staff, House Appropriations Cmte

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4872 (111th), H.R. 3590 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.